TARGETWATCH
LILinc
Viimeisin kurssi
75,70 SEK
22.7.2026
Viimeisin
85,00 SEK
+12.29%
Nousuvara
LINC
3 kk+12,29%1 kurssitavoitteet
6 kk+12,29%1 kurssitavoitteet
1 v+12,29%1 kurssitavoitteet
Max 1 kurssitavoitteet
SEB
RahoitusAsset Management

Tietoa yhtiöstä

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.99 million), the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB was founded in 1991 and based in Stockholm, Sweden.
Yahoo Finance

Viimeisin tavoitehinta

Tavoitehinta
85,00 SEK
Nousuvara
+12,29%
Viimeisin kurssi75,70 SEK

Sisäpiirikaupat: Linc

Ei sisäpiirikauppoja valitulle ajanjaksolle.

Lisää kurssitavoitteita: Linc

Analyytikko
Päivämäärä
Jul 17
Tavoitehinta
85,00 SEK